Middletown, DE -- (SBWIRE) -- 09/20/2013 -- VipStockReports.com screens the markets looking for Hot Emerging Micro-cap and Small cap stocks that look to Run High. Our team STRONGLY believes the penny stock market can powerfully reward average traders, and we are here to lead the way. Today our focus is on: Halozyme Therapeutics, Inc. (NASDAQ:HALO), Allscripts Healthcare Solutions Inc(NASDAQ:MDRX), Dynavax Technologies Corporation(NASDAQ:DVAX), Novavax, Inc.(NASDAQ:NVAX)
Halozyme Therapeutics, Inc.(NASDAQ:HALO) was a volume gainer of 1.81 million shares and the average volume of the stock remained 1.58 million shares. The stock opened the session at $10.25 and finished at the end of the day at $10.10 and the stock escalated +0.05%.The market capitalization of the stock remained 1.14 billion. The half-yearly trend of the stock remained positive +88.43%. Halozyme Therapeutics, Inc., a biopharmaceutical company, engages in the research, development, and commercialization of human enzymes. Its research focuses on human enzymes that transiently modify tissue under the skin to facilitate the delivery of injected drugs and fluids, or to alter abnormal tissue structures for clinical benefit.
For How Long HALO will fight for Profitability? Read This Trend Analysis report
In the preceding trading session, Allscripts Healthcare Solutions Inc(NASDAQ:MDRX) exchanged 1.80 million shares and the average volume remained 1.70 million shares. The stock closed the session at $15.01 with the gain of +2.46%. Tracking three months and 6 months trends, the stock was at of +10.37% and +10.94%, respectively. Allscripts Healthcare Solutions, Inc. provides clinical, financial, connectivity, and information solutions and related professional services to hospitals, physicians, and post-acute organizations primarily in the United States and Canada. The company operates through Software Delivery, Services Delivery, Client Support, Pathway Solutions.
Will MDRX Continue To Move Higher? Find Out Here
Dynavax Technologies Corporation (NASDAQ:DVAX) decreased -1.67% and its closing price was $1.18. The volume of the stock was 1.80 million shares and the average volume remained 1.30 million shares. Yesterday, the stock traded amid the day price range of $1.18 - $1.21. The market capitalization of the stock remained 215.93 million. The beta of the stock remained 3.12. Dynavax Technologies Corporation, a clinical-stage biopharmaceutical company, discovers and develops novel products to prevent and treat infectious and inflammatory diseases. It develops product candidates based on the use of immunostimulatory sequences and immunoregulatory sequences
Will DVAX Get Buyers Even After The Recent Rally? Find Out Here
Novavax, Inc. (NASDAQ:NVAX) exchanged 1.73 million shares in the previous trading session, and its average trading remained 3.54 million shares. NVAX dropped -1.56% and it closed the trading at $3.15. The market capitalization of the stock remained 481.06 million. YTD trend of the stock was positive +73.08%. Novavax, Inc., a clinical-stage biopharmaceutical company, focuses on developing recombinant protein nanoparticle vaccines to address a range of infectious diseases. The company?s technology platform is based on proprietary recombinant vaccine technology that includes virus-like particles (VLPs) and recombinant protein micelle vaccines.
Has NVAX Found The Bottom and Ready To Move Up? Find Out Here
We screen the markets looking for Hot Emerging Micro-cap and Small cap stocks that look to Run High. Once we find the 'Next Hot Penny Stock' with Monster Upside Potential we immediately Email it to you in our detailed VIP Report so you can Beat Rest of the Crowd!!
Our team STRONGLY believes the penny stock market can powerfully reward average traders, and we are here to lead the way.
VipstockReports.com newsletters and website: The disclaimer is to be read entirely and fully understood before using our website, or joining our newsletter email list. Never invest into a stock discussed on this website or the Vipstockalerts.com newsletter unless you can afford to lose your entire investment. Please consult with a certified financial advisor before making any investment decisions.
VipStockReports.com and any affiliates and information providers make no implied or express warranties on the information provided. Please verify quotes with your financial advisor before making investment decisions. This is not to be construed as a solicitation to buy or sell securities. As with any stock, the featured companies profiled on the VipstockReports.com web site and/or newsletter involve a high degree of volatility and risk, and all investors should know that they may lose a portion of or all of their investment if they decide to purchase any stocks.
Read Full Disclaimer at: http://www.vipstockreports.com/disclaimer/
Copyright © 2005-2013 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)